APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclosporine Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cyclosporine Drugs Industry Growth and Trends Forecast to 2032

29 December 2025100 pages

Choose your research edition.

Industry ResearchCyclosporine Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclosporine Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Cyclosporine Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclosporine Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclosporine Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Cyclosporine Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cyclosporine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cyclosporine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclosporine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cyclosporine Drugs market include Takeda Pharmaceutical, Sun Pharmaceuticals Industries, Novartis, Huadong Medicine, Otsuka Pharmaceutical, Apotex, Allergan, AbbVie and United Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cyclosporine Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cyclosporine Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyclosporine Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyclosporine Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cyclosporine Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cyclosporine Drugs Market by Company

Takeda Pharmaceutical

Sun Pharmaceuticals Industries

Novartis

Huadong Medicine

Otsuka Pharmaceutical

Apotex

Allergan

AbbVie

United Biotech

Teva Pharmaceuticals Industries

Santen Pharmaceuticals

Regenerx Biopharmaceuticals

Mckesson Medical Surgical

Mayne Pharma Group

Cyclosporine Drugs Segment by Type

Oral

Parenteral

Cyclosporine Drugs Segment by Application

Dry Eye

Rheumatoid Arthritis

Transplant Rejection Prophylaxis

Psoriasis

Autoimmune Myasthenia Gravis

Others

Cyclosporine Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclosporine Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclosporine Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclosporine Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cyclosporine Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cyclosporine Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cyclosporine Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cyclosporine Drugs Market Share by Region (2021-2026) Table 4. Global Cyclosporine Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cyclosporine Drugs Market Share by Region (2027-2032) Table 6. Global Cyclosporine Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cyclosporine Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cyclosporine Drugs Market Size Share by Type (2021-2026) Table 9. Global Cyclosporine Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cyclosporine Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cyclosporine Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cyclosporine Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cyclosporine Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cyclosporine Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cyclosporine Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cyclosporine Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cyclosporine Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cyclosporine Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cyclosporine Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cyclosporine Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cyclosporine Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cyclosporine Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cyclosporine Drugs Market Size Share by Application (2021-2026) Table 24. Global Cyclosporine Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cyclosporine Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cyclosporine Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cyclosporine Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cyclosporine Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cyclosporine Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cyclosporine Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cyclosporine Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cyclosporine Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cyclosporine Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cyclosporine Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cyclosporine Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cyclosporine Drugs Industry Trends Table 37. Cyclosporine Drugs Industry Drivers Table 38. Cyclosporine Drugs Industry Opportunities and Challenges Table 39. Cyclosporine Drugs Industry Restraints Table 40. Global Cyclosporine Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cyclosporine Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Cyclosporine Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cyclosporine Drugs Key Company Headquarters & Area Served Table 44. Global Cyclosporine Drugs Company, Product Type & Application Table 45. Global Cyclosporine Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cyclosporine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Pharmaceutical Company Information Table 49. Takeda Pharmaceutical Business Overview Table 50. Takeda Pharmaceutical Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Pharmaceutical Cyclosporine Drugs Product Portfolio Table 52. Takeda Pharmaceutical Recent Development Table 53. Sun Pharmaceuticals Industries Company Information Table 54. Sun Pharmaceuticals Industries Business Overview Table 55. Sun Pharmaceuticals Industries Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sun Pharmaceuticals Industries Cyclosporine Drugs Product Portfolio Table 57. Sun Pharmaceuticals Industries Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis Cyclosporine Drugs Product Portfolio Table 62. Novartis Recent Development Table 63. Huadong Medicine Company Information Table 64. Huadong Medicine Business Overview Table 65. Huadong Medicine Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Huadong Medicine Cyclosporine Drugs Product Portfolio Table 67. Huadong Medicine Recent Development Table 68. Otsuka Pharmaceutical Company Information Table 69. Otsuka Pharmaceutical Business Overview Table 70. Otsuka Pharmaceutical Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Otsuka Pharmaceutical Cyclosporine Drugs Product Portfolio Table 72. Otsuka Pharmaceutical Recent Development Table 73. Apotex Company Information Table 74. Apotex Business Overview Table 75. Apotex Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Apotex Cyclosporine Drugs Product Portfolio Table 77. Apotex Recent Development Table 78. Allergan Company Information Table 79. Allergan Business Overview Table 80. Allergan Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Allergan Cyclosporine Drugs Product Portfolio Table 82. Allergan Recent Development Table 83. AbbVie Company Information Table 84. AbbVie Business Overview Table 85. AbbVie Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. AbbVie Cyclosporine Drugs Product Portfolio Table 87. AbbVie Recent Development Table 88. United Biotech Company Information Table 89. United Biotech Business Overview Table 90. United Biotech Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. United Biotech Cyclosporine Drugs Product Portfolio Table 92. United Biotech Recent Development Table 93. Teva Pharmaceuticals Industries Company Information Table 94. Teva Pharmaceuticals Industries Business Overview Table 95. Teva Pharmaceuticals Industries Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Teva Pharmaceuticals Industries Cyclosporine Drugs Product Portfolio Table 97. Teva Pharmaceuticals Industries Recent Development Table 98. Santen Pharmaceuticals Company Information Table 99. Santen Pharmaceuticals Business Overview Table 100. Santen Pharmaceuticals Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Santen Pharmaceuticals Cyclosporine Drugs Product Portfolio Table 102. Santen Pharmaceuticals Recent Development Table 103. Regenerx Biopharmaceuticals Company Information Table 104. Regenerx Biopharmaceuticals Business Overview Table 105. Regenerx Biopharmaceuticals Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Regenerx Biopharmaceuticals Cyclosporine Drugs Product Portfolio Table 107. Regenerx Biopharmaceuticals Recent Development Table 108. Mckesson Medical Surgical Company Information Table 109. Mckesson Medical Surgical Business Overview Table 110. Mckesson Medical Surgical Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Mckesson Medical Surgical Cyclosporine Drugs Product Portfolio Table 112. Mckesson Medical Surgical Recent Development Table 113. Mayne Pharma Group Company Information Table 114. Mayne Pharma Group Business Overview Table 115. Mayne Pharma Group Cyclosporine Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Mayne Pharma Group Cyclosporine Drugs Product Portfolio Table 117. Mayne Pharma Group Recent Development Table 118. North America Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Cyclosporine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Cyclosporine Drugs Market Share by Country (2021-2026) Table 121. North America Cyclosporine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Cyclosporine Drugs Market Share Forecast by Country (2027-2032) Table 123. Europe Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Cyclosporine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Cyclosporine Drugs Market Share by Country (2021-2026) Table 126. Europe Cyclosporine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Cyclosporine Drugs Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Cyclosporine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Cyclosporine Drugs Market Share by Country (2021-2026) Table 131. Asia-Pacific Cyclosporine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Cyclosporine Drugs Market Share Forecast by Country (2027-2032) Table 133. Latin America Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Cyclosporine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Cyclosporine Drugs Market Share by Country (2021-2026) Table 136. Latin America Cyclosporine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Cyclosporine Drugs Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Cyclosporine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Cyclosporine Drugs Market Share by Country (2021-2026) Table 141. Middle East & Africa Cyclosporine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Cyclosporine Drugs Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cyclosporine Drugs Product Image Figure 3. Global Cyclosporine Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cyclosporine Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Cyclosporine Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Cyclosporine Drugs Market Share by Region (2021-2032) Figure 7. North America Cyclosporine Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cyclosporine Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cyclosporine Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cyclosporine Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cyclosporine Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Oral Image Figure 13. Global Oral Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Parenteral Image Figure 15. Global Parenteral Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Cyclosporine Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Cyclosporine Drugs Market Share by Type 2025 VS 2032 Figure 18. North America Cyclosporine Drugs Market Size Share by Type (2021-2032) Figure 19. Europe Cyclosporine Drugs Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Cyclosporine Drugs Market Size Share by Type (2021-2032) Figure 21. Latin America Cyclosporine Drugs Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Cyclosporine Drugs Market Size Share by Type (2021-2032) Figure 23. Dry Eye Image Figure 24. Global Dry Eye Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Rheumatoid Arthritis Image Figure 26. Global Rheumatoid Arthritis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Transplant Rejection Prophylaxis Image Figure 28. Global Transplant Rejection Prophylaxis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Psoriasis Image Figure 30. Global Psoriasis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Autoimmune Myasthenia Gravis Image Figure 32. Global Autoimmune Myasthenia Gravis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Cyclosporine Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Cyclosporine Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Cyclosporine Drugs Market Size Share by Application (2021-2032) Figure 38. Europe Cyclosporine Drugs Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Cyclosporine Drugs Market Size Share by Application (2021-2032) Figure 40. Latin America Cyclosporine Drugs Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Cyclosporine Drugs Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Cyclosporine Drugs Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Cyclosporine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Cyclosporine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Cyclosporine Drugs Market Share by Country (2021-2032) Figure 47. Europe Cyclosporine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cyclosporine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cyclosporine Drugs Market Share by Country (2021-2032) Figure 50. Asia-Pacific Cyclosporine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Cyclosporine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Cyclosporine Drugs Market Share by Country (2021-2032) Figure 53. Latin America Cyclosporine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Cyclosporine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cyclosporine Drugs Market Share by Country (2021-2032) Figure 56. Middle East & Africa Cyclosporine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Cyclosporine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Cyclosporine Drugs Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Parenteral
Applications
  • Dry Eye
  • Rheumatoid Arthritis
  • Transplant Rejection Prophylaxis
  • Psoriasis
  • Autoimmune Myasthenia Gravis
  • Others
Companies covered
  • Takeda Pharmaceutical
  • Sun Pharmaceuticals Industries
  • Novartis
  • Huadong Medicine
  • Otsuka Pharmaceutical
  • Apotex
  • Allergan
  • AbbVie
  • United Biotech
  • Teva Pharmaceuticals Industries
  • Santen Pharmaceuticals
  • Regenerx Biopharmaceuticals
  • Mckesson Medical Surgical
  • Mayne Pharma Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cyclosporine Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cyclosporine Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Cyclosporine Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Cyclosporine Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cyclosporine Drugs Market Size (2021-2032)
  8. 1.5.1 North America Cyclosporine Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cyclosporine Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cyclosporine Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cyclosporine Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cyclosporine Drugs Market Size Growth Rate (2021-2032)
2 Cyclosporine Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Oral
  3. 2.1.2 Parenteral
  4. 2.2 Global Cyclosporine Drugs Market Size by Type
  5. 2.2.1 Global Cyclosporine Drugs Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Cyclosporine Drugs Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Cyclosporine Drugs Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Cyclosporine Drugs Market Size by Regions
  9. 2.3.1 North America Cyclosporine Drugs Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Cyclosporine Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Cyclosporine Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Cyclosporine Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Cyclosporine Drugs Market Size Breakdown by Type (2021-2026)
3 Cyclosporine Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Dry Eye
  3. 3.1.2 Rheumatoid Arthritis
  4. 3.1.3 Transplant Rejection Prophylaxis
  5. 3.1.4 Psoriasis
  6. 3.1.5 Autoimmune Myasthenia Gravis
  7. 3.1.6 Others
  8. 3.2 Global Cyclosporine Drugs Market Size by Application
  9. 3.2.1 Global Cyclosporine Drugs Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Cyclosporine Drugs Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Cyclosporine Drugs Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Cyclosporine Drugs Market Size by Regions
  13. 3.3.1 North America Cyclosporine Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Cyclosporine Drugs Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Cyclosporine Drugs Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Cyclosporine Drugs Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Cyclosporine Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cyclosporine Drugs Industry Trends
  2. 4.2 Cyclosporine Drugs Industry Drivers
  3. 4.3 Cyclosporine Drugs Industry Opportunities and Challenges
  4. 4.4 Cyclosporine Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cyclosporine Drugs Revenue (2021-2026)
  2. 5.2 Global Cyclosporine Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cyclosporine Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Cyclosporine Drugs Company, Product Type & Application
  5. 5.5 Global Cyclosporine Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cyclosporine Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cyclosporine Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cyclosporine Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Cyclosporine Drugs Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 Sun Pharmaceuticals Industries
  8. 6.2.1 Sun Pharmaceuticals Industries Company Information
  9. 6.2.2 Sun Pharmaceuticals Industries Business Overview
  10. 6.2.3 Sun Pharmaceuticals Industries Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceuticals Industries Cyclosporine Drugs Product Portfolio
  12. 6.2.5 Sun Pharmaceuticals Industries Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Cyclosporine Drugs Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Huadong Medicine
  20. 6.4.1 Huadong Medicine Company Information
  21. 6.4.2 Huadong Medicine Business Overview
  22. 6.4.3 Huadong Medicine Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Huadong Medicine Cyclosporine Drugs Product Portfolio
  24. 6.4.5 Huadong Medicine Recent Developments
  25. 6.5 Otsuka Pharmaceutical
  26. 6.5.1 Otsuka Pharmaceutical Company Information
  27. 6.5.2 Otsuka Pharmaceutical Business Overview
  28. 6.5.3 Otsuka Pharmaceutical Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Otsuka Pharmaceutical Cyclosporine Drugs Product Portfolio
  30. 6.5.5 Otsuka Pharmaceutical Recent Developments
  31. 6.6 Apotex
  32. 6.6.1 Apotex Company Information
  33. 6.6.2 Apotex Business Overview
  34. 6.6.3 Apotex Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Apotex Cyclosporine Drugs Product Portfolio
  36. 6.6.5 Apotex Recent Developments
  37. 6.7 Allergan
  38. 6.7.1 Allergan Company Information
  39. 6.7.2 Allergan Business Overview
  40. 6.7.3 Allergan Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Allergan Cyclosporine Drugs Product Portfolio
  42. 6.7.5 Allergan Recent Developments
  43. 6.8 AbbVie
  44. 6.8.1 AbbVie Company Information
  45. 6.8.2 AbbVie Business Overview
  46. 6.8.3 AbbVie Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 AbbVie Cyclosporine Drugs Product Portfolio
  48. 6.8.5 AbbVie Recent Developments
  49. 6.9 United Biotech
  50. 6.9.1 United Biotech Company Information
  51. 6.9.2 United Biotech Business Overview
  52. 6.9.3 United Biotech Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 United Biotech Cyclosporine Drugs Product Portfolio
  54. 6.9.5 United Biotech Recent Developments
  55. 6.10 Teva Pharmaceuticals Industries
  56. 6.10.1 Teva Pharmaceuticals Industries Company Information
  57. 6.10.2 Teva Pharmaceuticals Industries Business Overview
  58. 6.10.3 Teva Pharmaceuticals Industries Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Teva Pharmaceuticals Industries Cyclosporine Drugs Product Portfolio
  60. 6.10.5 Teva Pharmaceuticals Industries Recent Developments
  61. 6.11 Santen Pharmaceuticals
  62. 6.11.1 Santen Pharmaceuticals Company Information
  63. 6.11.2 Santen Pharmaceuticals Business Overview
  64. 6.11.3 Santen Pharmaceuticals Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Santen Pharmaceuticals Cyclosporine Drugs Product Portfolio
  66. 6.11.5 Santen Pharmaceuticals Recent Developments
  67. 6.12 Regenerx Biopharmaceuticals
  68. 6.12.1 Regenerx Biopharmaceuticals Company Information
  69. 6.12.2 Regenerx Biopharmaceuticals Business Overview
  70. 6.12.3 Regenerx Biopharmaceuticals Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Regenerx Biopharmaceuticals Cyclosporine Drugs Product Portfolio
  72. 6.12.5 Regenerx Biopharmaceuticals Recent Developments
  73. 6.13 Mckesson Medical Surgical
  74. 6.13.1 Mckesson Medical Surgical Company Information
  75. 6.13.2 Mckesson Medical Surgical Business Overview
  76. 6.13.3 Mckesson Medical Surgical Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Mckesson Medical Surgical Cyclosporine Drugs Product Portfolio
  78. 6.13.5 Mckesson Medical Surgical Recent Developments
  79. 6.14 Mayne Pharma Group
  80. 6.14.1 Mayne Pharma Group Company Information
  81. 6.14.2 Mayne Pharma Group Business Overview
  82. 6.14.3 Mayne Pharma Group Cyclosporine Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Mayne Pharma Group Cyclosporine Drugs Product Portfolio
  84. 6.14.5 Mayne Pharma Group Recent Developments
7 North America
  1. 7.1 North America Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cyclosporine Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Cyclosporine Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cyclosporine Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Cyclosporine Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cyclosporine Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cyclosporine Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cyclosporine Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Cyclosporine Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cyclosporine Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cyclosporine Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst